secwatch.observer — SEC 8-K summary
======================================

Issuer:     HALOZYME THERAPEUTICS, INC. (HALO)
CIK:        0001159036
Form:       8-K
Filed at:   2026-08-18T20:04:09+00:00
Accession:  0001159036-26-000106
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Halozyme elects Dannielle Appelhans to board of directors
---------------------------------------------------------

- Dannielle Appelhans elected to Halozyme board on Aug 14, 2026, class with term ending at 2028 annual meeting.
- No initial committee assignment; will receive standard non-employee director compensation (cash, RSUs, options).
- No arrangements or related-person transactions disclosed in connection with her election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1159036/000115903626000106/0001159036-26-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1159036/000115903626000106/halo-20260814.htm
  HTML page:      https://secwatch.observer/filing/0001159036-26-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer